Kashyap Patel

Mechanism of Action and Preclinical Antitumor Activity of the Novel Hypoxia-Activated DNA Cross-Linking Agent PR-104

Adam V. Patterson, Dianne M. Ferry, Shelley J. Edmunds et al. · Clinical Cancer Research · 2007 · 243 citations · Full text

Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration

Shalini Wickramaratne Senarath Yapa, Jian Li, Kashyap Patel et al. · Antimicrobial Agents and Chemotherapy · 2014 · 157 citations · Full text

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Andrew Udy, Jeffrey Lipman, Paul Jarrett et al. · Critical Care · 2015 · 138 citations · Full text

Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study

Kashyap Patel, Kevin L. Sullivan, David Berd et al. · Melanoma Research · 2005 · 121 citations

Systemic Metastases, Surgical Oncology, Hepatic Artery +21

Oxygen Dependence and Extravascular Transport of Hypoxia-Activated Prodrugs: Comparison of the Dinitrobenzamide Mustard PR-104A and Tirapazamine

Kevin O. Hicks, Hilary Myint, Adam V. Patterson et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 70 citations

Oxygen Dependence, Oxidative Stress, Medicine +10